Table 3.
Age (wks) at sensitization | Day of sampling | Clinical grade | Inflammation | Demye- lination |
---|---|---|---|---|
2 | 7 | 0 | ++ | ++ |
3 | 7 | 0.5 | ++ | + |
4 | 7 | 0 | + | − |
6 | 7 | 1.0 | + | + |
8 | 7 | 1.0 | +/− | + |
10 | 7 | 2.0 | ++ | + |
++++, Total white matter involvement; +++, formation of plaques, fusion of areas of demyelination and inflammation; ++, perivascular and involvement of white matter; +, perivascular; +/−, little white matter involvement.